Inovio Pharmaceuticals, Inc. SEC filings INO
Inovio Pharmaceuticals, Inc. has 1,004 filings in SEC EDGAR's recent list, going back to Feb 20, 2008. Its latest annual report, Form 10-K, was filed on Mar 12, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Jul 10, 2026 | — |
| EFFECT | Filing | Jan 31, 2024 | — |
| CORRESP | Letter to the SEC | Jan 29, 2024 | — |
| UPLOAD | Letter from the SEC | Nov 16, 2023 | — |
| EFFECT | Filing | Apr 3, 2023 | — |
| POS EX | Filing | Mar 28, 2023 | — |
| POSASR | Filing | Mar 1, 2023 | — |
| UPLOAD | Letter from the SEC | Oct 14, 2022 | — |
| CORRESP | Letter to the SEC | Sep 29, 2022 | — |
| UPLOAD | Letter from the SEC | Sep 15, 2022 | — |
| UPLOAD | Letter from the SEC | May 1, 2020 | — |
| CORRESP | Letter to the SEC | Apr 24, 2020 | — |
| UPLOAD | Letter from the SEC | Apr 14, 2020 | — |
| EFFECT | Filing | Mar 31, 2020 | — |
| CORRESP | Letter to the SEC | Mar 27, 2020 | — |
| UPLOAD | Letter from the SEC | Mar 23, 2020 | — |
| EFFECT | Filing | Feb 13, 2020 | — |
| UPLOAD | Letter from the SEC | Feb 11, 2020 | — |
| CORRESP | Letter to the SEC | Feb 10, 2020 | — |
| D | Filing | Jan 24, 2020 | — |
| D | Filing | Aug 15, 2019 | — |
| EFFECT | Filing | Jun 8, 2018 | — |
| UPLOAD | Letter from the SEC | Jun 8, 2018 | — |
| CORRESP | Letter to the SEC | Jun 6, 2018 | — |
| CT ORDER | Filing | Mar 30, 2018 | — |
| CT ORDER | Filing | Mar 14, 2016 | — |
| EFFECT | Filing | Jun 5, 2015 | — |
| UPLOAD | Letter from the SEC | Jun 3, 2015 | — |
| CORRESP | Letter to the SEC | Jun 3, 2015 | — |
| CERTNAS | Auto-generated paper document | Sep 15, 2014 | — |
| 25 | Form 25 | Sep 12, 2014 | — |
| 8-A12B | Form 8-a12b | Sep 12, 2014 | — |
| EFFECT | Filing | Aug 8, 2014 | — |
| EFFECT | Filing | Feb 13, 2014 | — |
| CT ORDER | Filing | Feb 6, 2014 | — |
| CT ORDER | Filing | Feb 27, 2012 | — |
| EFFECT | Filing | Sep 23, 2011 | — |
| DEL AM | Filing | Sep 6, 2011 | — |
| UPLOAD | Letter from the SEC | Sep 9, 2010 | — |
| CT ORDER | Filing | Sep 3, 2010 | — |
| UPLOAD | Letter from the SEC | Aug 6, 2010 | — |
| CORRESP | Letter to the SEC | May 19, 2010 | — |
| CORRESP | Letter to the SEC | May 11, 2010 | — |
| UPLOAD | Letter from the SEC | Apr 28, 2010 | — |
| NT 10-Q | Filing | Aug 17, 2009 | Jun 30, 2009 |
| EFFECT | Filing | Jul 1, 2009 | — |
| EFFECT | Filing | Jul 1, 2009 | — |
| EFFECT | Filing | Jun 26, 2009 | — |
| 425 | Filing | May 18, 2009 | — |
| EFFECT | Filing | May 1, 2009 | — |
| 425 | Filing | May 1, 2009 | — |
| CT ORDER | Filing | Apr 30, 2009 | — |
| CORRESP | Letter to the SEC | Apr 29, 2009 | — |
| CORRESP | Letter to the SEC | Apr 20, 2009 | — |
| UPLOAD | Letter from the SEC | Apr 9, 2009 | — |
| 425 | Filing | Apr 8, 2009 | — |
| 425 | Filing | Mar 31, 2009 | — |
| 425 | Filing | Mar 26, 2009 | — |
| UPLOAD | Letter from the SEC | Feb 3, 2009 | — |
| UPLOAD | Letter from the SEC | Jan 6, 2009 | — |
| 425 | Filing | Dec 17, 2008 | — |
| 425 | Filing | Dec 8, 2008 | — |
| 425 | Filing | Nov 7, 2008 | — |
| 425 | Filing | Oct 2, 2008 | — |
| 425 | Filing | Jul 8, 2008 | — |
| UPLOAD | Letter from the SEC | Apr 3, 2008 | — |
Showing 66 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- INO (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Plymouth Meeting, PA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1055726
- Former names
- INOVIO BIOMEDICAL CORP (until May 11, 2010); GENETRONICS BIOMEDICAL CORP (until Apr 1, 2005); GENETRONICS BIOMEDICAL LTD (until Aug 3, 2001)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.